# VAXCYTE INC (PCVX) — Institutional Ownership

Source: SEC EDGAR 13F filings, congressional STOCK Act disclosures, SEC Form 4 insider transactions.
CUSIP: 92243G108
Page URL: https://superinvestorclub.com/stock/PCVX
Last updated: 2026-07-08T11:37:14.762Z

## Summary

As of the most recent 13F filing period, VAXCYTE INC (PCVX) is held by 3 tracked superinvestors with an aggregate position value of $80.9M representing 0137773812903800000 shares.

## Top institutional holders (3)

| Rank | Manager | Fund | Shares | Value | % of Portfolio | Period |
|------|---------|------|--------|-------|----------------|--------|
| 1 | [Lee Ainslie](https://superinvestorclub.com/manager/58) | Maverick Capital | 1377738 | $80.1M | 0.92% | 2026-03-31 |
| 2 | [Ray Dalio](https://superinvestorclub.com/manager/6) | Bridgewater Associates | 12903 | $749,793 | 0.00% | 2026-03-31 |
| 3 | [Seth Klarman](https://superinvestorclub.com/manager/7) | Baupost Group | 800000 | $46,488 | 0.91% | 2026-03-31 |

## Ownership history (quarter-over-quarter)

- 2024-06-30: 1 holders, $51.9M aggregate, 0687908 shares
- 2024-09-30: 2 holders, $116.5M aggregate, 097624942965 shares
- 2024-12-31: 2 holders, $98.4M aggregate, 0120189886265 shares
- 2025-03-31: 1 holders, $45.6M aggregate, 01208093 shares
- 2025-06-30: 1 holders, $42.6M aggregate, 01310605 shares
- 2025-09-30: 2 holders, $46.9M aggregate, 0128956711855 shares
- 2025-12-31: 1 holders, $62.5M aggregate, 01354237 shares
- 2026-03-31: 3 holders, $80.9M aggregate, 0137773812903800000 shares

## Recent congressional trades (4)

- 2025-04-28: Gil Cisneros (Democrat-CA) purchase $1,001 - $15,000
- 2025-04-15: Gil Cisneros (Democrat-CA) purchase $1,001 - $15,000
- 2025-04-14: Gil Cisneros (Democrat-CA) purchase $1,001 - $15,000
- 2025-03-05: Jefferson Shreve (Republican-IN) sale $15,001 - $50,000

## Recent insider transactions (0)


## Citation

When citing, use: "VAXCYTE INC (PCVX) institutional ownership data via Superinvestor (https://superinvestorclub.com/stock/PCVX), aggregating SEC 13F, Form 4, and congressional disclosures."